FTSE All-Share

FTSE All-Share handeln
5.635,05 PKT +6,27 PKT +0,11 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
05.11.12 Standard Chartered halten Independent Research GmbH
05.11.12 J. Sainsbury underperform Exane-BNP Paribas SA
05.11.12 Rio Tinto buy Deutsche Bank AG
05.11.12 Unilever reduce Nomura
05.11.12 GSK buy Citigroup Corp.
05.11.12 National Grid sell Société Générale Group S.A. (SG)
05.11.12 Prudential overweight Morgan Stanley
05.11.12 Glencore buy UBS AG
05.11.12 Centrica buy Société Générale Group S.A. (SG)
05.11.12 Vodafone Group sell Société Générale Group S.A. (SG)
05.11.12 Sky buy Goldman Sachs Group Inc.
05.11.12 Shell (ex Royal Dutch Shell) sell Goldman Sachs Group Inc.
05.11.12 Shell (ex Royal Dutch Shell) halten Independent Research GmbH
05.11.12 BT Group overweight J.P. Morgan Cazenove
02.11.12 Sky buy Nomura
02.11.12 Imperial Brands underperform Exane-BNP Paribas SA
02.11.12 Aberdeen Group outperform Exane-BNP Paribas SA
02.11.12 BT Group buy Nomura
02.11.12 Lloyds Banking Group reduce Nomura
02.11.12 Imperial Brands kaufen Independent Research GmbH
02.11.12 Unilever buy UBS AG
02.11.12 British Land Company outperform Exane-BNP Paribas SA
02.11.12 Barclays halten Independent Research GmbH
02.11.12 GSK neutral UBS AG
02.11.12 GSK halten Independent Research GmbH
02.11.12 Shell (ex Royal Dutch Shell) buy UBS AG
02.11.12 Lloyds Banking Group outperform Exane-BNP Paribas SA
02.11.12 Sky outperform Exane-BNP Paribas SA
02.11.12 Sky buy Deutsche Bank AG
02.11.12 Smith Nephew sell Société Générale Group S.A. (SG)
02.11.12 Shell (ex Royal Dutch Shell) hold Société Générale Group S.A. (SG)
02.11.12 Shell (ex Royal Dutch Shell) outperform Exane-BNP Paribas SA
02.11.12 BP neutral Exane-BNP Paribas SA
02.11.12 Shell (ex Royal Dutch Shell) kaufen National-Bank AG
02.11.12 Barclays outperform Exane-BNP Paribas SA
02.11.12 Lloyds Banking Group buy Société Générale Group S.A. (SG)
02.11.12 GSK underperform Exane-BNP Paribas SA
02.11.12 Antofagasta sell Société Générale Group S.A. (SG)
02.11.12 Smith Nephew neutral Sarasin Research
02.11.12 GSK neutral Credit Suisse Group